Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort.
Chanchlani N, Mortier K, Williams LJ, Muhammed R, Auth MKH, Cosgrove M, Fagbemi A, Fell J, Chong S, Zamvar V, Hyer W, Bisset WM, Morris MA, Rodrigues A, Mitton SG, Bunn S, Beattie RM, Willmott A, Wilson DC, Russell RK.
Chanchlani N, et al. Among authors: bisset wm.
J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):513-519. doi: 10.1097/MPG.0000000000002011.
J Pediatr Gastroenterol Nutr. 2018.
PMID: 29697550
Free article.